Cibc World Markets Corp Sells 19,389 Shares of Aflac Incorporated (NYSE:AFL)

Cibc World Markets Corp cut its position in shares of Aflac Incorporated (NYSE:AFL) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 80,340 shares of the financial services provider’s stock after selling 19,389 shares during the quarter. Cibc World Markets Corp’s holdings in Aflac were worth $8,310,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new stake in shares of Aflac during the fourth quarter valued at approximately $26,000. Darwin Wealth Management LLC bought a new stake in Aflac in the 3rd quarter valued at $34,000. BankPlus Trust Department bought a new stake in Aflac in the 4th quarter valued at $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the 3rd quarter valued at $38,000. Finally, OFI Invest Asset Management bought a new position in shares of Aflac during the 4th quarter worth about $38,000. 67.44% of the stock is currently owned by institutional investors.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 55,546 shares of company stock worth $5,863,616 in the last quarter. 0.80% of the stock is owned by company insiders.

Aflac Stock Down 1.0 %

NYSE:AFL opened at $107.27 on Wednesday. The stock’s fifty day moving average price is $105.60 and its two-hundred day moving average price is $107.65. The company has a market cap of $58.63 billion, a price-to-earnings ratio of 11.17, a P/E/G ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Wall Street Analyst Weigh In

AFL has been the subject of several recent research reports. Wells Fargo & Company dropped their price target on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. Keefe, Bruyette & Woods dropped their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Evercore ISI dropped their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Finally, BMO Capital Markets began coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $103.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.